Goldman Sachs Group »

Intra Cellular Therapies shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Intra Cellular Therapies

Tip: Access up to 7 years of quarterly data

All positions including Intra Cellular Therapies held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intra Cellular Therapies by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $41M 579k 71.62
2023-09-30 $20M 379k 52.09
2023-06-30 $21M 335k 63.32
2023-03-31 $25M 455k 54.15
2022-12-31 $19M 354k 52.92
2022-06-30 $36M 629k 57.08
2022-03-31 $29M 479k 61.19
2021-12-31 $12M 235k 52.34
2021-09-30 $22M 587k 37.27
2021-03-31 $28M 817k 33.93
2020-12-31 $19M 604k 31.80
2020-09-30 $3.7M 146k 25.66
2020-06-30 $15M 586k 25.67
2019-12-31 $7.2M 211k 34.31
2019-09-30 $858k 115k 7.47
2019-06-30 $1.8M 142k 12.97
2019-03-31 $1.3M 110k 12.18
2018-12-31 $980k 86k 11.41
2018-09-30 $1.5M 67k 21.69
2018-06-30 $1.2M 69k 17.67
2018-03-31 $1.3M 62k 21.06
2017-12-31 $1.3M 93k 14.48
2017-09-30 $3.6M 228k 15.78
2017-06-30 $7.2M 581k 12.42
2017-03-31 $2.2M 133k 16.25
2016-12-31 $1.3M 83k 15.09
2016-09-30 $4.0M 264k 15.24
2016-06-30 $3.5M 90k 38.82
2016-03-31 $692k 25k 27.82
2015-12-31 $1.5M 27k 53.79
2015-09-30 $1.1M 27k 40.03
2015-06-30 $1.7M 52k 31.95
2015-03-31 $349k 15k 23.90